Supraventricular tachyarrhythmias. Treatment with edrophonium.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D004077:Digoxin / Q000627:therapeutic use; D004491:Edrophonium / Q000009:adverse effects / Q000627:therapeutic use*; D004562:Electrocardiography; D005260:Female; D006339:Heart Rate; D006352:Heart Ventricles / Q000187:drug effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011802:Quinidine / Q000627:therapeutic use; D013610:Tachycardia / Q000188:drug therapy*
D000889:Anti-Arrhythmia Agents; D004491:Edrophonium; D004077:Digoxin; D011802:Quinidine